125 related articles for article (PubMed ID: 6586422)
1. Quantitative evaluation of the localization of a monoclonal antibody (791T/36) in human osteogenic sarcoma xenografts.
Pimm MV; Baldwin RW
Eur J Cancer Clin Oncol; 1984 Apr; 20(4):515-24. PubMed ID: 6586422
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies for radioimmunodetection of tumours and for targeting.
Baldwin RW; Embleton MJ; Pimm MV
Bull Cancer; 1983; 70(2):132-6. PubMed ID: 6575842
[TBL] [Abstract][Full Text] [Related]
3. Biodistribution and tumour localization of radiolabelled monoclonal antibody during continuous infusion in nude mice with human tumour xenografts.
Pimm MV; Clegg JA; Baldwin RW
Eur J Cancer Clin Oncol; 1987 May; 23(5):521-7. PubMed ID: 3477458
[TBL] [Abstract][Full Text] [Related]
4. Localization of anti-osteogenic sarcoma monoclonal antibody 791T/36 in a primary human osteogenic sarcoma and its subsequent xenograft in immunodeprived mice.
Pimm MV; Perkins AC; Armitage NC; Baldwin RW
Cancer Immunol Immunother; 1985; 19(1):18-21. PubMed ID: 3856475
[TBL] [Abstract][Full Text] [Related]
5. In vivo localization of anti-osteogenic sarcoma 791T monoclonal antibody in osteogenic sarcoma xenografts.
Pimm MV; Embleton MJ; Perkins AC; Price MR; Robins RA; Robinson GR; Baldwin RW
Int J Cancer; 1982 Jul; 30(1):75-85. PubMed ID: 6956558
[No Abstract] [Full Text] [Related]
6. Syngeneic anti-idiotypic antibody prevents localization of a murine monoclonal antibody in human tumour xenografts.
Pimm MV; Baldwin RW
Eur J Cancer; 1990; 26(5):567-8. PubMed ID: 2144742
[TBL] [Abstract][Full Text] [Related]
7. Selective localisation of two radiolabelled anti-sarcoma monoclonal antibodies in human osteosarcoma xenografts.
Bruland O; Fodstad O; Skretting A; Pihl A
Br J Cancer; 1987 Jul; 56(1):21-5. PubMed ID: 3476143
[TBL] [Abstract][Full Text] [Related]
8. Experience in the preparation and experimental use of immunocytostatics.
Embleton MJ; Pimm MV; Garnett MC; Rowland GF; Simmonds RG; Baldwin RW
Behring Inst Mitt; 1984 May; (74):108-12. PubMed ID: 6591915
[TBL] [Abstract][Full Text] [Related]
9. Differentiation between monoclonal antibody-defined antigens on a human osteogenic sarcoma cell line (791T) and tumor-localizing properties of the anti-791T/36 antibody.
Dawood F; Embleton MJ; Price MR; Pimm MV; Byers VS; Baldwin RW
Braz J Med Biol Res; 1986; 19(2):257-69. PubMed ID: 3470084
[TBL] [Abstract][Full Text] [Related]
10. Complement-dependent cytotoxicity of anti-human osteogenic sarcoma monoclonal antibodies.
Price MR; Pimm MV; Baldwin RW
Br J Cancer; 1982 Oct; 46(4):601-10. PubMed ID: 6958308
[TBL] [Abstract][Full Text] [Related]
11. Differences in tumour and normal tissue concentrations of iodine- and indium-labelled monoclonal antibody. II. Biodistribution studies in mice with human tumour xenografts.
Pimm MV; Perkins AC; Baldwin RW
Eur J Nucl Med; 1985; 11(8):300-4. PubMed ID: 4076238
[TBL] [Abstract][Full Text] [Related]
12. Biodistribution and tumour localization of a methotrexate-monoclonal-antibody 791T/36 conjugate in nude mice with human tumour xenografts.
Pimm MV; Clegg JA; Garnett MC; Baldwin RW
Int J Cancer; 1988 Jun; 41(6):886-91. PubMed ID: 3372062
[TBL] [Abstract][Full Text] [Related]
13. Localization of an anti-CEA monoclonal antibody in colo-rectal carcinoma xenografts.
Pimm MV; Armitage NC; Perkins AC; Smith W; Baldwin RW
Cancer Immunol Immunother; 1985; 19(1):8-17. PubMed ID: 3844977
[TBL] [Abstract][Full Text] [Related]
14. Comparative biodistributions and rates of catabolism of radiolabelled anti-CEA monoclonal antibody and control immunoglobulin in nude mice with human tumour xenografts showing specific antibody localization.
Pimm MV; Baldwin RW
Eur J Nucl Med; 1987; 13(5):258-63. PubMed ID: 3478194
[TBL] [Abstract][Full Text] [Related]
15. Differences between the catabolism and tumour distribution of intact monoclonal antibody (791T/36) and its Fab/c fragment in mice with tumour xenografts revealed by the use of a residualizing radiolabel (dilactitol-125I-tyramine) and autoradiography.
Demignot S; Pimm MV; Thorpe SR; Baldwin RW
Cancer Immunol Immunother; 1991; 33(6):359-66. PubMed ID: 1878889
[TBL] [Abstract][Full Text] [Related]
16. Interferon-alpha conjugation to human osteogenic sarcoma monoclonal antibody 791T/36.
Pelham JM; Gray JD; Flannery GR; Pimm MV; Baldwin RW
Cancer Immunol Immunother; 1983; 15(3):210-6. PubMed ID: 6577942
[TBL] [Abstract][Full Text] [Related]
17. In vivo radiolocalization of antiosteogenic sarcoma monoclonal antibodies in osteogenic sarcoma xenografts.
Nakamura T; Sakahara H; Hosoi S; Yamamuro T; Higashi S; Mikawa H; Endo K; Toyama S
Cancer Res; 1984 May; 44(5):2078-83. PubMed ID: 6585270
[TBL] [Abstract][Full Text] [Related]
18. Antitumor monoclonal antibodies for radioimmunodetection of tumors and drug targeting.
Baldwin RW; Pimm MV
Cancer Metastasis Rev; 1983; 2(1):89-106. PubMed ID: 6352009
[TBL] [Abstract][Full Text] [Related]
19. The localization of human breast carcinomas by radiolabelled monoclonal antibodies.
Rainsbury RM
Br J Surg; 1984 Oct; 71(10):805-12. PubMed ID: 6237710
[TBL] [Abstract][Full Text] [Related]
20. Superior localisation and imaging of radiolabelled monoclonal antibody E48 F(ab')2 fragment in xenografts of human squamous cell carcinoma of the head and neck and of the vulva as compared to monoclonal antibody E48 IgG.
Gerretsen M; Quak JJ; Suh JS; van Walsum M; Meijer CJ; Snow GB; van Dongen GA
Br J Cancer; 1991 Jan; 63(1):37-44. PubMed ID: 1989663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
